Getinge AB (publ)
Getinge AB (publ) (GNGBY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNGBY · as of Jun 9, 2026
Key Statistics
Explore Getinge AB (publ) Data
gngby stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 0.0%
Competitors & Peers
gngby competitorsGNGBY
ABT
ALGN
BIO
BRKR
CNMDStock Performance
Full HistoryAbout Getinge AB (publ)
Getinge AB (publ) is a prominent global medical technology provider, delivering comprehensive products and solutions primarily to operating rooms, intensive care units, and sterilization departments. …
what is getinge ab (publ) · gngby stock overview · getinge ab (publ) company profile · who is getinge ab (publ) ceo · gngby OTC · getinge ab (publ) headquarters · getinge ab (publ) business segments
About Stock Overview & Key Data
Getinge AB (publ) (GNGBY) is a Healthcare company in the Medical - Devices industry, listed on OTC since Aug 17, 2012. As of the latest trading session, GNGBY stock price is $20.15, with a market capitalization of $5.5B. The stock has returned +2.28% over the past 12 months and -14.80% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Getinge AB (publ) stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Getinge AB (publ) reported revenue of $35.0B and net income of $2.3B. For detailed data — including Getinge AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Getinge AB (publ) (GNGBY) stock price is $20.15. The stock is traded on OTC under the ticker symbol GNGBY. The 52-week range is $18.70 – $24.67.